Skip to content
News Online 360

Users Discontinuing Weight-Loss Injections Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Image of medical syringe and scale
Weight management often requires ongoing approaches.

A recent study reveals that people who stop using popular GLP-1 drugs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end conventional diet and exercise programs.

Published data in a prominent medical journal points out that while overweight people often shed substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"People purchasing these medications need to be aware of the danger of fast rebound weight gain when the treatment is stopped," stated researcher Dr. Susan Jebb.

That rate of regain means a reversion to original weight within about 18 months.

Weighing Treatments

The analysis, which looked at dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with conventional dieting.

Scientists emphasize that people who lose weight through lifestyle changes alone generally see a less rapid weight regain—approximately 0.1 kg a month—once they finish.

The Reason for the Fast Regain

Nutrition scientists suggest the way of the drugs accounts for the heightened regain.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement means hunger is unsuppressed, making overeating far more likely."

A Chronic Condition?

Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the likelihood of relapse, the treatment might need to be life-long.

This view is supported by drug manufacturers, who state that the findings "emphasize the long-term character of obesity," comparing it to managing conditions like hypertension.

Patient Accounts

People who have discontinued the medication explain a intense resurgence of appetite.

"It felt as if something activating and you're instantly extremely hungry," recalled one woman.

The struggle is compounded if patients have not adopted sustainable lifestyle or habit modifications during treatment.

Widespread Interest

Recent estimates show that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among women compared to males.
  • The middle-aged age group shows the greatest level of interest.
  • Many access the medications through private prescriptions rather than public health services.

In conclusion, experts caution that while the jabs are potent agents for weight loss, they are not a magic solution and lasting health benefits hinges on integrated lifestyle changes.

The writer

Lori Chapman

A seasoned journalist with over a decade of experience covering international affairs and digital media trends.

News Online 360

Type to search articles.